CareDx, Inc (CDNA) Financials
CDNA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 411.1 million | 97.5 million |
| Dec. 31, 2025 | 413.2 million | 110.1 million |
| Sept. 30, 2025 | 432.3 million | 121.2 million |
| June 30, 2025 | 444.3 million | 116.9 million |
CDNA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | 514000 | 9.8 million |
| Dec. 31, 2025 | 19.7 million | 8.1 million |
| Sept. 30, 2025 | 36.1 million | 8.4 million |
| June 30, 2025 | 8.9 million | 9.4 million |
CDNA Net Income
No data available :(
CDNA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 187.2 million | 17.8 million | 24.5 million |
| Dec. 31, 2025 | 177.2 million | - | 19.7 million |
| Sept. 30, 2025 | 194.2 million | - | 27.6 million |
| June 30, 2025 | 186.3 million | - | 29.1 million |
CDNA Shares Outstanding
CDNA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 3.8 million | 21.4 million | 60.9 million | 30.4 million |
| Dec. 31, 2025 | 1.6 million | 19.3 million | 59.6 million | 30.9 million |
| Sept. 30, 2025 | 1.3 million | 16.8 million | 52.9 million | 24.4 million |
| June 30, 2025 | 1.0 million | 16.8 million | 52.0 million | 24.3 million |
CDNA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 117.7 million | 33.6 million |
| Dec. 31, 2025 | 108.4 million | 36.2 million |
| Sept. 30, 2025 | 100.1 million | 31.3 million |
| June 30, 2025 | 86.7 million | 28.7 million |
CDNA Revenue by Segment
Graph available only for paid members. Upgrade to see it.
CDNA
Price: $22.25
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.16 USD
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 944000
Ebitda: -11.9 millionMarket Capitalization: 1.1 billion